'Difficult To Compound' Drug List Gets Revived By FDA
Armed with new authority to regulate compounding pharmacies, the U.S. Food and Drug Administration on Wednesday revived efforts to identify medicines that are especially hard for the specialty manufacturers to produce...To view the full article, register now.
Already a subscriber? Click here to view full article